Bossart Dominik
Known title: EVPCIK: 0001781833
Associated companies
Transaction History
| BCO | ▼ Sell | Open Market | 10,000 | $850K | 3/13/2024 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 329 | $27K | 3/3/2024 | View on chart |
| BCO | ▲ Buy | Grant | 2,166 | $0 | 3/1/2024 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 338 | $28K | 3/1/2024 | View on chart |
| BCO | ▼ Sell | Other | 578 | — | 2/24/2024 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 858 | $70K | 2/24/2024 | View on chart |
| BCO | ▼ Sell | Other | 6,374 | — | 2/24/2024 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 148 | $12K | 2/24/2024 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 225 | $18K | 2/14/2024 | View on chart |
| BCO | ▼ Sell | Other | 884 | — | 2/14/2024 | View on chart |
| BCO | ▲ Buy | Grant | 1,252 | $0 | 2/14/2024 | View on chart |
| BCO | ▲ Buy | Option Exercise | 1,036 | $0 | 1/1/2024 | View on chart |
| BCO | ▼ Sell | Open Market | 15,000 | $1.1M | 6/6/2023 | View on chart |
| BCO | ▲ Buy | Grant | 2,635 | $0 | 3/3/2023 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 221 | $14K | 3/1/2023 | View on chart |
| BCO | ▼ Sell | Other | 636 | — | 2/24/2023 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 61 | $4K | 2/24/2023 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 159 | $10K | 2/20/2023 | View on chart |
| BCO | ▲ Buy | Grant | 8,268 | $0 | 2/16/2023 | View on chart |
| BCO | ▲ Buy | Grant | 2,944 | $0 | 2/16/2023 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 800 | $51K | 2/16/2023 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 1,341 | $80K | 12/3/2022 | View on chart |
| BCO | ▲ Buy | Grant | 2,711 | $0 | 3/1/2022 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 60 | $4K | 2/24/2022 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 156 | $11K | 2/21/2022 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 159 | $11K | 2/20/2022 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 1,403 | $97K | 2/17/2022 | View on chart |
| BCO | ▲ Buy | Grant | 5,488 | $0 | 2/17/2022 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 261 | $23K | 1/1/24 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Brink's Gets CMA Approval for NCR Atleos Deal Remedy
Brink's received acceptance in principle from the UK's CMA regarding a proposed remedy for its pending acquisition of NCR Atleos. The company also reported Q2 2026 results and confirmed that a potential sale of UK assets will not impact expected $200M in annual synergies. This regulatory progress is a key step in finalizing the transaction.
Brink's Gets CMA Approval for NCR Atleos Deal Remedy. Brink's received acceptance in principle from the UK's CMA regarding a proposed remedy for its pending acquisition of NCR Atleos. The company also reported Q2 2026 results and confirmed that a potential sale of UK assets will not impact expected $200M in annual synergies. This regulatory progress is a key step in finalizing the transaction.